10 Years of EthOss - A Commitment to Bone Health

When Dr. Peter Fairbairn and Dr. Paul Harrison first launched EthOss back in 2013, they weren't just looking to create another dental product. They were looking to change the philosophy of bone grafting entirely. The goal was simple yet profound: the body wants to heal; let’s work with it.

This patient-centric mission has remained the heartbeat of the company for over a decade. By focusing on synthetic solutions, EthOss has empowered clinicians to achieve predictable results.

Timeline

The road from a research concept to a global leader in regenerative dentistry has been marked by significant milestones. Here is how the last decade has shaped the EthOss we know today:

2010 - R&D
Initial Research & Development begins, looking at improvements to existing BTCP/Calcium Sulphate materials.

2010-2013 - Testing Period
Rigorous clinical testing to ensure safety and efficacy.

2013 - EthOss Founded
The company was incorporated.

2015 - CE Marking
After gaining the CE mark, EthOss is able to launch and distribute in the EU.

2017 - Exhibition Launch
EthOss exhibit at IDS for the first time, expanding into markets across Europe.

2019 - Re-Brand
EthOss went through a re-brand, launching the "Grow Stronger" motive, reinforcing the commitment to both bone health and professional education.

2019 - Awards
Recognition begins to pour in as EthOss wins 'Best SME' in the National UK Business Awards.

2020 - More Territory
Expansion continues with a South American partnership in Colombia.

2021 - Queen's Awards
EthOss received the prestigious Queen's Award for Enterprise: International Trade.

2022 - Centre of Excellence
EthOss hosted their first Centre of Excellence event in London to foster clinical community and excellence.

2024 - EdgeX Launch
A new era of digital learning begins with the launch of the EdgeX education platform.

2026 - Ongoing Success
EthOss is now available in over 75 countries.

The success of the past ten years is only the foundation for what comes next. As the dental industry shifts toward more biological and minimally invasive approaches, EthOss finds itself at the forefront of a scientific revolution.

A message from Peter Fairbairn

"Alongside this growth, we are also entering a new era of the scientific understanding of bone grafts and the role
of the host immune system. Recent publications in the area of osteoimmunology have cast a new light on what is “really happening” when we graft, highlighting the importance of biocompatible materials which can up-regulate the host immune response, reducing pain and inflammation and accelerating healing times.

I can’t wait to see what the future has in store for EthOss"
- Prof. Dr. Peter Fairbairn.

What started as a partnership between two founders has grown into a global community of thousands of clinicians. From small private practices to massive dental institutions, EthOss has proven that when you prioritise the biology of the patient, and focus on a commitment to bone health, success follows.

As we look toward the next ten years, our commitment to education, scientific rigor, and patient outcomes remains stronger than ever.

Thank you to everyone who has been part of this incredible journey so far.

To be a part of our upcoming app, featuring new a case study group and fostering a wider dentist community, sign up here.